Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06111027 · ClinicalTrials.gov registry record · Phase 1
Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT06111027 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 40 participants.
The verdict
NCT06111027, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The general aim of the study was to provide evidence for the usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (laryngeal dystonia). This work addresses a clinical need to develop alternative or auxiliary treatments for a rare voice disorder with limited treatment options.
Interventions
- DEVICE Vibro-tactile stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2024-10-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06111027
The ClinicalTrials.gov registry entry for NCT06111027 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vibro-tactile stimulation is the first listed.
NCT06111027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06111027 about?
NCT06111027 is a clinical study titled "Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia". The general aim of the study was to provide evidence for the usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (laryngeal dystonia). This work addresses a clinical need to devel...
What is the current status of trial NCT06111027?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2023-11-21. Estimated completion is 2024-10-31.
What interventions are being tested in trial NCT06111027?
The interventions under investigation include: Vibro-tactile stimulation (DEVICE).
Who is sponsoring clinical trial NCT06111027?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.